2014 News Releases

Webcast ImageWebcast - Live
Q1 2014 AtriCure, Inc. Earnings Conference Call
04/24/14 at 4:30 p.m. ET
Q1 2014 AtriCure, Inc. Earnings Conference Call
Thursday, April 24, 2014 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
04/04/14AtriCure to Announce First Quarter 2014 Financial Results
WEST CHESTER, Ohio--(BUSINESS WIRE)--Apr. 4, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device provider, will release its financial results for the first quarter of 2014 on Thursday, April 24, 2014. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Thursday, April 24, 2014 to discuss its first quarter 2014 financial results. A live webcast of the conference call will be available online from... 
Printer Friendly Version
02/28/14AtriCure to Present at the Cowen and Company 34th Annual Health Care Conference
WEST CHESTER, Ohio--(BUSINESS WIRE)--Feb. 28, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device provider, today announced that it will present at the Cowen and Company 34th Annual Health Care Conference at the Boston Marriott Copley Place on Wednesday, March 5, 2014. Management is scheduled to present at 9:20 a.m. Eastern Time. A live audio webcast and replay of the presentation will be available for 30 day... 
Printer Friendly Version
02/27/14AtriCure Reports Fourth Quarter and Full Year 2013 Financial Results
2013 revenue of $81.9 million – up 16.6% 2013 U.S. sales of $62.3 million – up 18.4% Fourth quarter revenue of $21.9 million – up 19.2% WEST CHESTER, Ohio--(BUSINESS WIRE)--Feb. 27, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation (“Afib”) medical device provider, today announced fourth quarter and full year 2013 financial results. “We are pleased with our team’s performanc... 
Printer Friendly Version
02/13/14AtriCure Prices Public Offering of Common Stock
WEST CHESTER, Ohio--(BUSINESS WIRE)--Feb. 13, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device provider, today announced the pricing of its previously announced underwritten public offering of 4,250,000 shares of its common stock at a public offering price of $19.25 per share. AtriCure is offering 3,023,025 shares and selling stockholders are offering 1,226,975 shares of common stock. In connection with the offering, Atr... 
Printer Friendly Version
02/12/14AtriCure Announces Commencement of Public Offering of Common Stock
WEST CHESTER, Ohio--(BUSINESS WIRE)--Feb. 12, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device provider, today announced that AtriCure and certain selling stockholders intend to offer shares of AtriCure common stock in a public offering. AtriCure also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock to cover over-allotments, if any. AtriCure plans to use the net proceeds... 
Printer Friendly Version
02/04/14AtriCure to Announce Fourth Quarter and Full Year 2013 Financial Results
WEST CHESTER, Ohio--(BUSINESS WIRE)--Feb. 4, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device provider, will release its financial results for the fourth quarter and full year 2013 on Thursday, February 27, 2014. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Thursday, February 27, 2014 to discuss its fourth quarter and full year 2013 financial results. A live webcast of the conference call wil... 
Printer Friendly Version
01/20/14AtriCure to Present at the Leerink Swann 2014 Global Healthcare Conference
WEST CHESTER, Ohio--(BUSINESS WIRE)--Jan. 20, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device provider, today announced that it will present at the Leerink Swann 2014 Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Wednesday, February 12, 2014. Management is scheduled to present at 11:30 a.m. Eastern Time. A live audio webcast and replay of the presentation will be available for 3... 
Printer Friendly Version
01/09/14AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2013 and Issues 2014 Guidance
WEST CHESTER, Ohio--(BUSINESS WIRE)--Jan. 9, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading atrial fibrillation medical device provider, today announced preliminary financial results for fourth quarter and full year 2013 and issued 2014 financial guidance. Preliminary revenue for the fourth quarter of 2013 is expected to be approximately $21.9 million, reflecting growth of approximately 19% over the fourth quarter of 2012. Based on this prelimin... 
Printer Friendly Version
01/02/14AtriCure Completes Acquisition of Estech
WEST CHESTER, Ohio--(BUSINESS WIRE)--Jan. 2, 2014-- AtriCure, Inc. (Nasdaq: ATRC), a leading Atrial Fibrillation medical device provider, today announced the completion of the previously announced acquisition of Endoscopic Technologies, Inc. d/b/a Estech (“Estech”). Estech develops and markets a portfolio of innovative surgical ablation devices that enable physicians to perform a variety of traditional and minimally invasive procedures using Estech’s pro... 
Printer Friendly Version